FDAnews Drug Daily Bulletin

BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement for Two New Drug Products

Aug. 20, 2012
BioSyent announced that its subsidiary BioSyent Pharma has signed an exclusive licensing and distribution agreement with a European partner for two new products that will be marketed by its hospital products division. The products will be launched after Health Canada approval.